Pod Insights This Podcast Will Kill You Ep 181 PCOS: Beyond the cysts About this episode What’s in a name? What can you really tell from a label like “polycystic ovarian syndrome”? And how much of that is more misconception than truth? The answer, as it turns out, is the former. In this episode, we delve into the world of PCOS, a world that shows us how preconceived notions of health and disease, gender and sexuality can do far more harm than good. For many people with PCOS, this condition violates society’s expectations of how you should look, act, or feel. And the resulting stigma and shame deepens the silence that often surrounds PCOS and leads to inadequate treatment and medical gaslighting. But thanks to the work of some incredible advocates, that silence is slowly fading. Tune in to discover the many lessons that PCOS can teach us, if only we are willing to learn.
Support this podcast by shopping our latest sponsor deals and promotions at this link: https://bit.ly/3WwtIAu
See omnystudio.com/listener https://omnystudio.com/listener for privacy information.
Transcript 14,466 words · 10 speakers
0:01 Speaker 00 This is exactly right.
0:06 Speaker 01 Hey, I'm Niall Rogers. This fall, I'll be driving across the country, meeting some of today's coolest and most fascinating artists. We'll explore the stories before the moments that changed everything. Because every musician remembers the moment where it all began. Experience Before the Moment, a Lincoln original series on the iHeartRadio app, YouTube, or wherever you get your podcasts.
0:38 Speaker 02 This is Jacob Goldstein from What's Your Problem? Running a business is hard enough. Don't make it harder with a dozen apps that don't talk to each other. One for sales, another for inventory, a separate one for accounting. That's software overload. Odoo is the all-in-one platform that replaces them all. CRM, accounting, inventory, e-commerce, HR. Fully integrated, easy to use, and built to grow with your business. Thousands have already made the switch. Why not you? Try Odoo for free at O D O O dot com. That's Odoo dot com.
1:15 Speaker 03 Hi, my name's Logan. I'm a transgender man. I use he/him pronouns and I have PCOS. My symptoms first started really appearing when I hit puberty. My periods would last a week on average, and they were very heavy. The cramps would be so bad that I couldn't walk, I couldn't sleep. I would just lay awake at night in agony despite taking pain medications. I also had very severe acne, and I had a lot of excess body and facial hair. If I didn't shave or pluck my hair, I could actually grow like this scraggly little chin beard, which was very affirming to me as a young trans masculine person. That was probably the only benefit of having PCOS was the masculizing features.
2:00 Speaker 03 By the time I was 19, my periods became even more painful, if that was possible, and even more regular. At one point, I went 10 months without a period. December 2018 is when I first experienced a cyst bursting. I was sitting in a college math final at the time, and I remember being in so much pain from my abdomen that I could barely breathe. I managed to finish the final, but I could hardly walk because of the pain, so I was rushed to the ER. When we got there, I was not treated well. They started off by accusing me of faking my pain to get opioids, but soon after, they thought that it could be appendicitis. I had to get blood drawn and a CAT scan.
2:41 Speaker 03 They actually ended up bursting one of the veins in my arm, trying to do the die for the CAT scan, so that was also not a fun experience. When the doctor finally came in to give me a diagnosis, or so I thought, all he really told me was, "Your appendix is fine, but you have multiple cysts on both your ovaries, so just go on birth control." And then I was dismissed right after with no diagnosis. The next year that followed, I had to get a lot of blood work and scans done, but no one seemed to understand what was wrong with me. I started birth control, but immediately became extremely depressed and suicidal.
3:21 Speaker 03 My body reacted so poorly that I had to quit after like a month. It was actually very terrifying how it changed my mental state. And once I stopped the birth control, I really wasn't given any other options for treatment. At some point, a doctor pulled me to the side and said, "I looked at your records, and I'm gonna formally diagnose you with PCOS. You have elevated testosterone, facial hair, irregular periods, and multiple cysts on both ovaries." I'll never forget her telling me that I was lucky that I had lean PCOS, which basically meant, "You have PCOS, but at least you're skinny." Once again, I was told my only options for treatment were birth control, which did not
4:05 Speaker 03 work before, or to get pregnant, much to my horror. By this time, I was aware that I was transgender, and I told her birth control makes me suicidal. So she said, "In that case, I should just go to therapy and go on a diet." I was 20 years old and 125 pounds at the time. Needless to say, the diet didn't help. I lived in chronic pain for the next few years with both my physical and emotional states causing me a lot of harm. It wasn't until I decided to start testosterone for my gender dysphoria that I actually felt like myself again. As a result of taking testosterone, my period stopped, my mental state stabilized, and I
4:50 Speaker 03 was happy and pain-free for the first time in a very long time. I remember bringing this up to my new doctor and her telling me, "Some bodies just function better on different hormones." I've now been living without PCOS symptoms for the past three years, and the quality of my life has greatly improved. I'm a bioengineer, and it really breaks my heart that this is the state of medical care for people who menstruate. I experienced a lot of sexism and a lot of transphobia throughout the whole process. All the assumptions doctors made about me at the time were made through these heterosexual cisgender lenses. They assumed that I didn't want to look masculine, that I'd eventually get pregnant, and that
5:34 Speaker 03 only birth control and estrogen-based pills would work for my body. But this was never the case, and I suffered so much as a result. Transgender people are often left out of these conversations, and I think it's important for people to know just how distressing it can be to have your pain and your identity dismissed by the medical field.
6:41 Speaker 04 Logan, thank you so much for sharing your story with us. It really is so meaningful and important to like get to hear these stories of like what it is actually like to live with PCOS. I think it really, it really helps so much.
6:57 Speaker 05 Yeah, it really provides so much context for us, for everyone listening. And thank you so much for, for sharing your story with us.
7:07 Speaker 04 Hi, I'm Erin Welsh.
7:08 Speaker 05 And I'm Erin Allman Updike.
7:10 Speaker 04 And this is This Podcast Will Kill You.
7:13 Speaker 05 Welcome to PCOS. Long awaited, I feel like.
7:16 Speaker 04 So long awaited. I mean, I wonder, I didn't do this search, but I wonder if you like searched our email.
7:24 Speaker 05 Oh, gosh.
7:24 Speaker 04 What the first suggestion for PCOS would be.
7:27 Speaker 05 Had to be years ago and probably, probably even before we did endometriosis, which was how many years ago now? Long time.
7:34 Speaker 04 2019? Was that? No, no.
7:38 Speaker 05 I don't remember. I have no idea.
7:39 Speaker 04 It was later. I don't remember either. It's fine.
7:41 Speaker 05 But it's been a minute.
7:42 Speaker 04 It's been a minute.
7:43 Speaker 05 And PCOS has been on our radar since then and before. And I am thrilled for this episode and also honestly embarrassed by how little I knew when I thought that I knew.
8:01 Speaker 05 I was diagnosed with PCOS in 2013.
8:03 Speaker 04 Mm hmm. I remember.
8:04 Speaker 05 Yeah. And I went through all of med school and all of residency. So I thought that I had a pretty good handle on PCOS. I learned so much, Erin.
8:12 Speaker 04 Yeah. I, same, same. I mean, I do not have PCOS as far as I know, but I thought, I thought I was like, oh yeah, I know what this is.
8:22 Speaker 05 Yeah.
8:23 Speaker 04 My gosh.
8:24 Speaker 05 Yeah.
8:25 Speaker 04 And so like, I'm just so, I think that this was a moment where I was so, I'm so grateful that we get to do this podcast.
8:33 Speaker 05 Same.
8:34 Speaker 04 Where, because part of it selfishly is like, oh, I feel like I know more about this now. Like I, there were, I had all these misconceptions. There were things that I finally realized. But I think also like, this is, so many people have similar misconceptions.
8:48 Speaker 05 I know. Exactly. Like, it's never just us.
8:51 Speaker 04 It's never just us.
8:52 Speaker 05 Yeah. So we're really excited.
8:55 Speaker 04 Yeah.
8:56 Speaker 05 Maybe sometimes it is just us.
8:57 Speaker 04 Maybe it is just us. But in any case.
9:00 Speaker 05 In any case.
9:01 Speaker 04 I'm excited. But before we get into the full picture of PCOS.
9:07 Speaker 05 It's quarantine time.
9:08 Speaker 04 Quarantine time. What are we drinking?
9:11 Speaker 05 We're drinking Under Revision. Those were bracket hands.
9:16 Speaker 04 Yeah, I was gonna say, in case you're not watching this.
9:18 Speaker 05 You're just listening.
9:20 Speaker 04 Yes, Under Revision, because truly, like, I feel like our, our perception of this is constantly changing and needs to change in many ways to deliver better care and better empathy and awareness. So.
9:34 Speaker 05 We'll get into so much detail on it, but tell us first, Erin, what's in Under Revision?
9:39 Speaker 04 It's, it's, it's a placebo-rita version, and it's so good. It's lavender syrup and lemon juice and club soda.
9:49 Speaker 05 It's like a little lavender lemonade situation.
9:51 Speaker 04 And relaxing. Love it.
9:53 Speaker 05 Yum.
9:54 Speaker 04 Yeah.
9:54 Speaker 05 We'll post the full recipe on our website, thispodcastwillkillyou.com. We'll post a video of Erin Welsh making it.
10:01 Speaker 04 I'm so sorry. Yeah, we're gonna try.
10:05 Speaker 05 On our social medias, like Instagram and the TikTok and the Facebook, et cetera. We're on Blue Sky as well, so if you're not following us, you should consider doing that. If you haven't yet rated and reviewed and subscribed to our podcast on your favorite podcatcher, iHeart Podcasts, Apple Podcasts, Spotify, we'd love it if you do that. If you're not yet subscribed to the Exactly Right YouTube Network channel, consider doing that.
10:34 Speaker 05 We're there.
10:35 Speaker 04 Just a gentle recommendation, a nudge.
10:38 Speaker 05 A nudge in the right direction. And we have a website.
10:42 Speaker 04 Exactly right direction. Sorry.
10:44 Speaker 05 Oh, that's good.
10:45 Speaker 04 Thank you. Thank you.
10:48 Speaker 05 And finally, we have a website. It's called thispodcastwillkillyou.com. And on it, you can find merch, you can find Patreon, you can find bookshop.org affiliate accounts and a Goodreads list, and Bodemobile, who does our music, and all of our sources, and so much more.
11:01 Speaker 04 So much more.
11:04 Speaker 04 That was great. And I think there's nothing else to cover except PCOS. So let's take a break and begin. OK, can't wait.
11:14 Speaker 01 Hey, I'm Niall Rogers, producer, songwriter, guitarist, and co-founder of the group Chic. A great song has a way of defining a moment, a moment of joy, heartbreak, or anything in between.
11:31 Speaker 01 This fall, I'll be driving across the country, dropping in on some of the coolest, most fascinating artists working today. We'll go deep into their lives and careers and hear what it was like before the moment that made them. From hitmakers like Miguel.
11:48 Speaker 00 That last year, finishing that record was the hardest experience of my life, regardless of how everyone else buys into this. I believe in this, and I'm gonna push.
11:59 Speaker 01 To rising stars like Alex Warren.
12:03 Speaker 06 You know, a song is a story, and the verse is setting the scene. And for me, at least, it's allowing me to be personal and vulnerable with the audience, whether it's about my wife and I'm being vulnerable about her, or it's about, you know, my parents and I'm being vulnerable to them. And it's almost like a cinematic piece in a way where each song tells that beautiful story.
12:21 Speaker 01 It's gonna be one hell of a trip. Experience Before the Moment, a Lincoln Original Series on the iHeart Radio app, YouTube, or wherever you get your podcasts.
12:33 Speaker 07 Hey, what's up? This is Kelvin Washington from The Odd Couple with Rob Parker and Kelvin Washington. Buy smart, drive for less, and trade for more. That's Toyota affordability, and it starts with a great deal on off-road-ready Tacoma or a half-ton Tundra, two of Toyota's longest-lasting trucks, combining power for work, tech for adventures, and style in between. Built on a reputation for quality and reliability, Toyota trucks are known for holding their value, which could mean big savings when it's time for your next Toyota. So get a great deal today and a great value tomorrow. ShopToyota.com for more. Toyota, let's go places.
13:26 Speaker 05 PCOS stands for polycystic ovarian syndrome, which really makes it sound like it's a disease where you have cysts on your ovaries. This should be pretty straightforward. It's not that, Erin.
13:39 Speaker 04 It's not that.
13:40 Speaker 05 It's not that.
13:41 Speaker 04 That was my misconception, number one. I was like, surely the name must be a clue as to what's going on here.
13:47 Speaker 05 Not, not even really a good clue at all, actually.
13:50 Speaker 04 Yeah.
13:51 Speaker 05 What PCOS really is, is an endocrine disorder, which means it's a disorder of our hormones and not just like one or two of our hormones. No, no. Today, we're going to get to talk about almost all of the hormones that we use and have in our bodies.
14:09 Speaker 04 It's a lot of them.
14:10 Speaker 05 And their effect on all of our body systems, okay? Yeah. There is not a single test that we can do to diagnose PCOS, but rather there are a list of criteria.
14:23 Speaker 04 Okay.
14:24 Speaker 05 And you have to fulfill two of three of these criteria to earn, I guess, the diagnosis of PCOS. And this list underscores some, though not all, of the possible, and I'm going to put this in quotes, "symptoms", because we're going to get into it, but some of the possible symptoms of PCOS. And so I thought that that's where we would start, is how we actually diagnose PCOS. And then we'll talk about what we know about what PCOS means in terms of the risks of various chronic diseases. And then we can get as deep or stay as shallow as you want in terms of what we know about the like nitty gritty pathophysiology of what's causing this.
15:05 Speaker 04 How much do we actually know about the nitty gritty of the pathophysiology that's causing this?
15:10 Speaker 05 Erin, we know both a lot and so little.
15:13 Speaker 04 I mean, that's, that's typical, yeah.
15:15 Speaker 05 It is, isn't it? And then we'll talk about how we treat it. And my goal is to do this in 20 minutes, so we'll see if that's going to happen, okay? It won't.
15:23 Speaker 04 It's quite a lofty goal.
15:25 Speaker 05 I know. You should see all the words on my page. So there has been fluctuation over the years over these diagnostic criteria. But at this point, there's pretty well established guidelines on how we diagnose PCOS. So to make this diagnosis, you need two out of three of the following criteria. One is hyperandrogenism, and we'll talk about what that means. And this can be either clinical, so symptoms that you can see on a person, or biochemical, so looking at lab tests. You have to have oligomenorrhea or amenorrhea, so few periods or not having any periods at all. And polycystic ovarian morphology. So you need two out of three of those. So let's talk about what those actually mean, like what they would look like, right?
16:11 Speaker 04 Right.
16:11 Speaker 05 In English.
16:13 Speaker 05 So hyperandrogenism means an elevated amount of androgens, which are steroid hormones. We often think of testosterone, and testosterone is one of the androgens. But there's a lot of others. DHEA, androstenedione, there's a whole bunch, okay? And so you can determine whether a person has what is considered hyperandrogenism by measuring the levels of those hormones in a person and comparing that to what we see in typical females. And this is, again, we're talking about people with ovaries here, and that is entirely the focus of PCOS at this point. Asterix abound.
16:55 Speaker 04 Quick question.
16:56 Speaker 05 Okay.
16:57 Speaker 04 When you are, let's say you are being tested for these hormone levels, what does that test involve?
17:04 Speaker 05 Those are, if you're testing for hormone levels, it's going to be blood tests.
17:07 Speaker 04 Okay.
17:08 Speaker 05 What exact hormones people are going to test for can vary depending on who is doing that test. One of the important things is to make sure that you're doing enough testing to rule out other androgenic disorders. Because your adrenals produce androgens. There's other, like, known disorders where we know, like, oh, you have a deficiency in, say, this enzyme that produces a specific clinical syndrome that's different than PCOS.
17:30 Speaker 04 Okay.
17:31 Speaker 05 And so you have to do enough of the blood tests to make sure that you're ruling out these other things. And then if you see still an increase in androgens, and again, this is already where we can get some variation because you might have an increase, you might not have an increase. But this is just one possible criteria. And you can look at a number of different androgens. So that's one.
17:52 Speaker 04 I already have so many questions.
17:54 Speaker 05 I know.
17:54 Speaker 04 Okay, so that like where it where what is the source of the excess androgens?
18:01 Speaker 05 You're jumping so far ahead. Okay.
18:04 Speaker 04 Okay, sorry, sorry. We'll get there. We'll get there.
18:08 Speaker 05 Ultimately, the main source of the excess androgens is the ovary. But the question of why is is at the heart of it.
18:15 Speaker 04 Is that? Yeah. Okay.
18:17 Speaker 05 But ultimately, the ovaries are producing excess androgens.
18:20 Speaker 04 And I just I swear, two more quick questions, just because I'm trying to get a sense of what elevated means.
18:26 Speaker 05 Yeah.
18:26 Speaker 04 So is this how how much do hormones fluctuate during the day, during the month, during the year, etc.? And so then how much is excess? How is excess determined? Or like, how is greater than average determined? What's is there a standard deviation? Like, what's the vibe?
18:43 Speaker 05 This is a great question, Erin. There's not like a number cutoff necessarily. So every lab that you do a lab test at is going to have their what is called like normal range or typical range. And for hormones like testosterone, or DHEA, or estrogen, or progesterone, or any of those, they're going to have a normal range for females, and they're going to have a normal range for males. And so if it is higher than that normal range for females, then that would be considered hyperandrogenism. And that could be if you're looking at free or total testosterone, or it could be one of these other hormones.
19:16 Speaker 04 Okay.
19:18 Speaker 05 I don't have like exact numbers, and you're right that it can vary day to day. It can vary during the time of day as well. So again, this can get quite complicated.
19:27 Speaker 04 Okay, sorry.
19:28 Speaker 05 It doesn't have to be bio. It's okay. Don't apologize. I love your questions.
19:34 Speaker 05 It does not have to be biochemical evidence, though. We also can see what's considered clinical evidence of hyperandrogenism. And that usually there's three main things that we think of. Acne, usually more severe acne, sometimes cystic acne, but not necessarily. Androgenic alopecia, aka scalpel, like male pattern hair hair loss.
19:55 Speaker 04 Right.
19:55 Speaker 05 And hercetism, which I always have to look up how to pronounce because I. That you said it first because I would have gotten it wrong. Hurstism, which is hair growth, like coarse, thick hair growth that specifically grows to longer than five millimeters. So not just tiny, tiny little hairs in androgen dependent areas. So that means places like the underarms, the pubic area, the face. And this is a kind of tricky one because there's a grading scale that in theory, one should use to determine how much would be considered excess or like Hurstism truly. Right. And there's also going to be like racial and ethnic variation in hair patterns to begin with. Totally.
20:38 Speaker 05 But, but that is also one of the possible clinical criteria. So that's all just hyperandrogenism. That's one thing that someone might have to put them on this list of possible PCOS. The second is ovulatory dysfunction, which means people either aren't ovulating at all, and then therefore they're not having any menses, or they're ovulating infrequently or irregularly. And so they're having very infrequent or irregular menstrual cycles. Exactly how infrequent or like how far apart they have to be, or how irregular depends in part on how far you are from menarche or that first menstrual period, because it's quite typical in the first few years to have irregular menstrual cycles. Okay.
21:21 Speaker 05 But if you are more than three years after your first menstrual cycle, then anything less than eight per year or greater than 35 days apart would be considered oligomenorrhea, or having few menstrual cycles. But that's again, so that's, that's one. So ovulatory dysfunction. And then the third and final is polycystic ovarian morphology, which does not really mean that you have a bunch of cysts on your ovaries, but means that if you look on ultrasound in the ovaries, you see a bunch of, and by a bunch, I mean 20 or more visible follicles that are arrested in an early stage of development. So we're born in with all, if you have ovaries,
22:04 Speaker 05 your ovaries have as many eggs in there as they're going to have. And typically in response To these hormonal cycles every month, one like multiple follicles start to mature, but then one takes over, matures completely, and then is released during ovulation. And what happens in PCOS is that multiple follicles start to grow and then grow to a certain point, but then are arrested in their development without ever having one that takes over and is released, which is why you have a ligal or a menoria because you're not ovulating. And then it's also why you have so many of these kind of follicles that are arrested at a stage in development that is before they get to ovulation.
22:48 Speaker 04 Okay, so you've got a bunch of these like not fully.
22:53 Speaker 05 Developed.
22:54 Speaker 04 Developed.
22:54 Speaker 05 Follicles.
22:55 Speaker 04 Matured follicles just hanging out at the ovary.
22:58 Speaker 05 Exactly.
22:59 Speaker 04 Causing like little grape clusters.
23:00 Speaker 05 Yeah, they look like little grape clusters.
23:02 Speaker 04 Okay.
23:03 Speaker 05 Sometimes on ultrasound, you might not see specific follicles, but you would have an overall larger volume, like greater than 10 milliliters volume without having one dominant follicle. Because if you have just one that's burst or ready for ovulation, they can get quite large, large.
23:17 Speaker 04 Okay, okay.
23:19 Speaker 05 Now, one thing that's new in the most recent guidelines from 2023 is that you don't necessarily have to do an ultrasound to look for those polycystic ovaries. You also could diagnose polycystic ovarian morphology by looking at AMH, which is another hormone that you would check via a blood test.
23:35 Speaker 04 Okay.
23:35 Speaker 05 That we've talked about, I think in our infertility episodes. Or in menopause.
23:40 Speaker 04 Not sure. Yeah.
23:41 Speaker 05 I know. I know. We mentioned it in menopause as well. But this is a hormone that relates to like how many follicles are still in existence in your ovary kind of a thing.
23:51 Speaker 04 Interesting. Okay.
23:53 Speaker 05 And having an elevated level of AMH is suggestive of PCOS. But again, here, there's not like an exact cutoff value yet for this, which is interesting in and of itself.
24:04 Speaker 05 So that's how we diagnose it. You gotta have two out of those three.
24:07 Speaker 04 Okay, so either you have this hyperandrogenism.
24:10 Speaker 05 Mm hmm.
24:11 Speaker 04 Um, infrequent or no periods.
24:15 Speaker 05 Mm hmm.
24:17 Speaker 04 What's
24:17 Speaker 05 And polycystic
24:18 Speaker 04 Yeah.
24:18 Speaker 05 Ovarian morphology.
24:20 Speaker 04 Yeah, in the name, yeah.
24:21 Speaker 05 In the name.
24:21 Speaker 04 I was like, what's the third?
24:24 Speaker 05 And so because there are these three different criteria and you only need two out of three to have a diagnosis, it leads to four different, what are called phenotypes of PCOS. So one of the options is that you have all three, you meet all three of these criteria and that would be called phenotype A. The second option is that you have evidence of hyperandrogenism and evidence of ovulatory dysfunction without having polycystic ovaries.
24:52 Speaker 04 Okay.
24:52 Speaker 05 We'll call them polycystic ovaries. They're not cis. And that would be phenotype B. And those two together are called classic PCOS. And they account for an estimated two thirds of people with PCOS. So two thirds of people with PCOS will have evidence of hyperandrogenism, either clinical or on lab tests. And they'll have ovulatory dysfunction with or without having polycystic ovarian morphology on ultrasound. The third phenotype, phenotype C, someone will have hyperandrogenism and on ultrasound, polycystic ovarian morphology, but without necessarily having any issues in terms of their ovulation. So not having a ligament area.
25:34 Speaker 05 And then phenotype D is ovulatory dysfunction and polycystic ovarian morphology, but no evidence of hyperandrogenism.
25:44 Speaker 04 Hmm, all right.
25:45 Speaker 05 Okay.
25:47 Speaker 04 Why?
25:48 Speaker 05 Why is a great question. Okay.
25:50 Speaker 04 Yeah.
25:51 Speaker 05 So just looking at all of those, like, there's a, there's a why question and then there's a huge part that's missing already. Okay, in these diagnostic criteria. Because those criteria give us a lot of insight into some of the symptoms as well as some of the consequences of PCOS.
26:08 Speaker 04 Right.
26:09 Speaker 05 So an ovulation, which can happen very commonly in PCOS, can result in infertility or reduced fertility. And PCOS is the major cause, is estimated to be like the number one cause of an ovulatory infertility. So if you're not ovulating and you can't get pregnant when you want to be pregnant, PCOS is the number one cause of that. In addition, this anovulation also leads to an increased risk of endometrial cancer down the line. And that's because your uterus, because of the hormones that are floating around, is out here like getting ready to have an egg implant. It's getting ready, it's getting ready, it's getting ready. That egg never comes. You never menstruate.
26:53 Speaker 05 Your uterus lining is proliferating this whole time, and that proliferation increases the risk of cancer in this continually proliferating tissue.
27:01 Speaker 04 Okay.
27:03 Speaker 05 The hyperandrogenism that we see in PCOS, that we can see, may or may not be associated with symptoms that are undesirable, right? It depends on someone's perception of what those symptoms are. Male pattern hair growth or hair loss may or may not be something that is distressing to someone. Acne, most people are not a fan of acne. But this, all of these definitions are missing one of the huge, very clear, well-defined major factors of PCOS, and that is its relationship to insulin resistance.
27:42 Speaker 04 Yeah.
27:44 Speaker 05 So insulin resistance leads to glucose intolerance, and that puts people at risk for type 2 diabetes, as well as a whole bunch of other metabolic complications, hyperlipidemia, so having elevated cholesterol levels. That puts you at risk for cardiovascular disease. It puts you at risk for hypertension and so much more. And PCOS also gets quite a lot of attention as it relates to obesity, which I always put in quotes, because obesity is, it's considered a disease in medicine that is defined entirely based on BMI. And BMI is not an indicator of health.
28:25 Speaker 04 Right.
28:26 Speaker 05 Elevated BMI is associated with PCOS, but whether this is cause or consequence is very much still up for debate.
28:35 Speaker 04 Do I feel like is a lot of some of the symptoms associated or the that are prevalent with PCOS?
28:42 Speaker 05 So
28:42 Speaker 04 Is it cause or consequence? Yeah.
28:44 Speaker 05 Yeah, but all of these and and here's what's really important about that is that all these other symptoms, and there are a lot, so like increased risk of insulin resistance, risk for type 2 diabetes, risk for hyperlipidemia, even people who have PCOS are also at an increased risk for obstructive sleep apnea. We don't know the mechanism there, but all of those risks increase regardless of BMI. They exist regardless of BMI. We know that, or we think at least from the data that we have so far, which is mostly in mouse models, that PCOS might be related to changes in adipose tissue, like the way that your adipose tissue responds to insulin or things like that,
29:27 Speaker 05 and how it like uptakes glucose and things like that.
29:30 Speaker 04 Yeah.
29:30 Speaker 05 But all of the other complications and metabolic complications in PCOS are prevalent regardless of BMI. And in like BMI matched case control studies, they are elevated in PCOS regardless of BMI.
29:50 Speaker 05 Just like in people without PCOS, in some cases, an elevated BMI can also put you at higher risk for some of these other metabolic complications. So again, what is the cause and what is the consequence? We don't know.
30:00 Speaker 04 Right.
30:01 Speaker 05 What we do know, and what is prevalent enough that it has made it into the 2023 guidelines, is the very real problem of fat shaming that happens in PCOS and weight stigma, like enough so that the awareness of this fat shaming and stigma is in the PCOS guidelines of like, you need to be aware of this if you're a clinician and not do it.
30:25 Speaker 05 But like you said, we do not know exactly how this metabolic dysfunction happens at the beginning. Like, what are the core causes of it?
30:40 Speaker 04 And how does, how do other hormones play into this?
30:46 Speaker 05 Oh, my gosh, Erin.
30:47 Speaker 04 What's, what's, what's the, the timeline, the sequence, the cascade?
30:53 Speaker 05 If I, if I could tell you a step by step cascade, I would have a lot more clarity as to what the heck is going on. Um, but I can give you some more detail. Okay.
31:01 Speaker 04 Yeah.
31:01 Speaker 05 To kind of understand a lot of what's going on in PCOS, we can first understand what's called our HPO axis. This is our hypothalamic pituitary ovarian axis or gonadal axis. Because you have one if you have testes too. So in your hypothalamus, you are releasing hormones. This is a part in your brain. You're releasing hormones. The one that is important in PCOS is called gonadotropin releasing hormone. And it is being pulsed out. It is normal. It is typical in our brains. It's not being released all the time, but we pulse it out in phases. Your brain is like, yep, give a little bit. Yep, give a little bit. Its job is to travel to our pituitary and tell our pituitary,
31:46 Speaker 05 which is another part of our brain, to secrete other hormones, luteinizing hormone, LH, and follicle stimulating hormone, FSH. We've talked about these in our infertility or pregnancy episodes. These two hormones' job is to travel through our bloodstream, go to our ovaries and modulate the production of estrogen and progesterone, and make our ovaries mature one follicle, release it and ovulate, right? This whole system, our HPO axis, works on a system of both positive and negative feedback loops. Right?
32:22 Speaker 04 Right.
32:22 Speaker 05 So one part of our brain tells another part of our brain, tells our ovaries, and those hormones go back to our brain and they're like, hey, we're here, so calm down, right?
32:31 Speaker 04 Yeah, yeah, yeah, yeah.
32:32 Speaker 05 In PCOS, there is a wrench in this system.
32:37 Speaker 05 What exactly the first wrench is, we don't know.
32:43 Speaker 05 So we know that the pulsatility of this gonadotropin-releasing hormone, GnRH, in PCOS is increased. So we see more and more frequent pulsatility of GnRH from our hypothalamus.
32:58 Speaker 04 Right.
32:58 Speaker 05 What that does is it tells our pituitary, "Ooh, keep going, keep going, keep going," and actually leads to a disruption in the LH versus FSH ratios.
33:07 Speaker 04 Oh, and so instead of like it being, okay, now ovulate, it's like, oh, maybe, maybe, maybe, maybe it's just like less of a strong message?
33:17 Speaker 05 Yeah, and the message is like, mature, mature, mature, mature, mature, mature, a bunch of follicles, bunch of follicles, but no, there's no ovulate signal.
33:24 Speaker 04 There's no release. Okay.
33:25 Speaker 05 There's no release signal, right? And that, because that LH is then going to our ovaries, and it's being like, make, make, make androgens, make androgens, make androgens. Then there's also something else going on because that hyperandrogen secretion should negative feedback onto our hypothalamus and be like, hey, stop. But that negative feedback is impaired. We don't exactly know why.
33:49 Speaker 04 Hmm.
33:50 Speaker 05 Then, okay, here's where it gets even more complicated, Erin.
33:53 Speaker 04 Okay, okay.
33:54 Speaker 05 Where does insulin resistance play into this?
33:57 Speaker 04 That's what I'm trying to figure out.
33:58 Speaker 05 We know
33:59 Speaker 04 Yeah.
34:00 Speaker 05 that insulin resistance, tissue-level insulin resistance, leads to an increase in insulin production, right? Because if your body is trying to regulate glucose, insulin is in charge of that, and if your tissues aren't responding to insulin, insulin is binding to the receptors it's supposed to, but it's not doing its job, so you can't collect that glucose, then your body's going to make more insulin, because it's like, hey, there's too much glucose floating around. We need more insulin, more insulin, more insulin. That hyperinsulinemia feeds back onto the ovaries and tells them, by a reason I don't understand, to make more androgens. Okay.
34:44 Speaker 04 I mean, okay, but no, I don't understand.
34:46 Speaker 05 Exactly. No, we don't know why. So in short, we know that all of these feedback loops are sort of not working the way that they would typically.
34:56 Speaker 04 Disrupted in some way, yeah.
34:58 Speaker 05 There's more and more evidence, because we used to think like, oh, it's just the ovaries. And there's some evidence in like mice and rats that like disruption at the level of the ovary, just like a tendency to excess androgen secretion to begin with can produce things like polycystic ovarian morphology.
35:15 Speaker 04 Okay.
35:15 Speaker 05 But it again, doesn't account for the lack of this negative feedback loop. It doesn't necessarily account for this insulin resistance piece of it. So there's more evidence that these other groups of hormones that act more in our brains called kiss peptides and other, like other types of hormones as well, are likely involved. So I guess the point of all of this is to say, A, number one, it's complicated.
35:39 Speaker 04 Yeah.
35:40 Speaker 05 And B, number one, while we know a lot.
35:43 Speaker 04 B, number two, or B, number one?
35:45 Speaker 05 Whatever.
35:49 Speaker 05 A, number one, it's complicated. B, number two,
35:53 Speaker 05 we know a lot about the features of these disruptions. Increased GnRH pulsatility.
36:00 Speaker 04 Right.
36:01 Speaker 05 Increased androgens, insulin resistance, leading to more increased androgens. We also see like a decrease in sex hormone binding globulin because of these androgens. So like there's all these feedback loops that are very well documented and drawn in all these papers, but we do not know what the first underlying issue really is.
36:21 Speaker 04 Right.
36:22 Speaker 05 Which means that all of our treatments that we have are addressing individual parts of the issue, but not coming close to like curing anything or really getting to like one drug or one mechanism fixing this cascade.
36:39 Speaker 04 So do we think that it is one mechanism?
36:42 Speaker 05 That is an excellent question, Erin. No idea.
36:46 Speaker 04 Okay.
36:47 Speaker 05 Especially because when you think of all of these different phenotypes, right? I said that there are four different phenotypes. They also are associated with like differential risk in things like insulin resistance.
36:59 Speaker 04 Okay.
37:00 Speaker 05 So types A and B, that like classic PCOS picture, something like 80% of people with this phenotype will have evidence of insulin resistance and therefore might be at higher risk of things like diabetes. Phenotype C, we see still a significantly increased insulin resistance, but like 60% compared to 80%. And in phenotype D, which is the one where people have no clinical hyperangiotinism, about 40% of them, we see insulin resistance. But in all of these, the incidence of type 2 diabetes and is like four times higher in people with PCOS compared to people without PCOS, regardless of BMI.
37:39 Speaker 04 Uh huh.
37:40 Speaker 05 Though that incidence does increase with increasing BMI.
37:44 Speaker 04 Okay, and so basically the the outcome of this like domino, like the path that the dominos take.
37:55 Speaker 05 Right.
37:56 Speaker 04 Might be different, just, but we don't know why. It might be different, but that's what results in these different phenotypes. But the end result, for the most part, is similar in terms of health consequences.
38:08 Speaker 05 I mean, it is similar. It is not exactly the same.
38:12 Speaker 04 Right.
38:13 Speaker 05 It is similar. And then it is also like not exactly the same in terms of even those initial dominos, right? Because in some people, we see this hyperangiotinism and in some, we don't, but we still call it PCOS. Is that really the same disease or not?
38:27 Speaker 04 Yeah, is, yeah.
38:28 Speaker 05 Is it? We don't know right now. We really don't know. Um, we don't, because we also don't know like what actually causes PCOS.
38:37 Speaker 04 Right.
38:38 Speaker 05 It's very strongly genetic. There is a big heritability component.
38:42 Speaker 04 It's like 70% heritable.
38:44 Speaker 05 Yeah. And that's not necessarily all strictly genetic. There's like at least 20 different gene loci in different populations. There's not one single gene. But there's also evidence of like epigenetic changes that we don't really know what is the trigger for these changes. But there's likely some epigenetic things that are involved in the like increased risk of PCOS. And then there's likely other environmental factors at play that we don't really understand, right? Like, what are all of these other triggers?
39:12 Speaker 04 I I'm gonna say it here because I didn't put any of this in my notes, but I didn't want to get into the evolutionary. There are like a lot of different papers I read about the evolutionary origins of PCOS as proposed by certain researchers. And it is, and I was like, ultimately, we don't understand what PCOS is. And so how can we really talk about what? Like, how can we test these hypotheses? If we don't know what it's caused by?
39:41 Speaker 05 Right.
39:41 Speaker 04 And yeah, so that I didn't, I don't have anything about that.
39:47 Speaker 05 I mean, yeah, because we don't, I feel like we don't even have a good, we have a clinical definition, right? We can diagnose this.
39:53 Speaker 04 Clinical definition, yeah.
39:54 Speaker 05 But are all, are all of these phenotypes are all PCOS the same? I don't know. We don't know.
39:59 Speaker 04 We don't know.
40:00 Speaker 05 In terms of what we do about it and how we treat it, it really depends on what we're worried about, what the symptoms are that a patient or a person is worried about. Because a lot of the symptoms of PCOS are related to these androgenic hormones and related to this HPO axis. A lot of times, we rely on birth control as one of the first line treatments for PCOS, especially combination birth control, like estrogen containing birth control. Because what that does is it helps kind of override a lot of this HPO axis. It's going to negate any of these ovulatory dysfunctions. It's going to decrease your risk of endometrial cancer. And the estrogen effect especially can help to alleviate
40:45 Speaker 05 a lot of the symptoms of excess androgens, if those symptoms are unwanted, like acne and hirsutism. Because the estrogen, what it does is it de, it it helps to address this decrease in sex hormone binding globulin, which then helps to decrease the amount of free testosterone that's circulating. Sometimes, though, we might use anti-androgen-specific medications like spironolactone or other medicines if we're targeting some of those hyperandrogen symptoms as a concern. But none of those are going to address the metabolic effects, right? Birth control is not going to change insulin resistance if that's present. By the way, we don't have a test for insulin resistance. There's no test.
41:27 Speaker 05 We don't have a way to test for insulin resistance.
41:31 Speaker 04 Huh.
41:32 Speaker 05 We can test for risk of diabetes, but diabetes is not just insulin resistance. It's, and it's, we see our diabetes episodes. There's other ways that you can get diabetes besides just insulin resistance. But insulin resistance can lead to diabetes if you then have impaired glucose tolerance. But insulin resistance is like a first step if that's the pathway.
41:57 Speaker 04 Yeah.
41:58 Speaker 05 And we can only like see it if it's come to the point of, okay, you have an increase in your A1C or you have an increase in your fasting glucose.
42:06 Speaker 04 Okay.
42:06 Speaker 05 But that's not directly a marker for insulin resistance itself. And we don't have a test for that that's easy to do.
42:15 Speaker 04 I just assumed that we did.
42:17 Speaker 05 Nope, we don't.
42:18 Speaker 04 Which explains why it's not part of the clinical picture.
42:21 Speaker 05 Exactly, because you can't test for it.
42:23 Speaker 04 You can't test for it.
42:24 Speaker 05 Right? You cannot test for it. So, but if there is evidence, especially of like glucose intolerance, right? Like increased A1C or something like that, then you can address that with metformin is usually the first line, and that's a drug that we use for diabetes. It helps to increase insulin sensitivity in our tissues. It sometimes can also cause weight loss, which may or may not be desired, depending on the situation. What's very, very interesting about metformin is that it also has data that it helps to regulate ovulation. And what exactly is the mechanism there? Like, does that give us any insight into what is going on here? I don't know that it does, but I just still think it's so interesting.
43:06 Speaker 04 Right. Is there, does that, is that, does that help shine a light on the link between this whole process?
43:12 Speaker 05 I think it helps shine a light on the- Because when you look at these, we should post one of these like graphs of of what these feedback loops look like and how they're disrupted in PCOS. There is a strong link between insulin resistance and hyperinsulinemia and androgen production in the ovaries. So we know that that's like an inward arrow.
43:32 Speaker 04 Okay.
43:33 Speaker 05 There's just no backward arrow that that goes like then why does the insulin resistance come up in the first place?
43:38 Speaker 04 Right, connecting the dots in that first.
43:40 Speaker 05 Yeah, yeah. Like, is insulin resistance actually the primary mechanism? I don't know. But then why do we see anyways? It's much. But for people who maybe want to get pregnant and are struggling with infertility, sometimes metformin can then be used to help alleviate the anovulation. It is not first line if the goal is pregnancy, though. Usually, first line what we use is a medicine called letrazol or another similar medicine that triggers ovulation.
44:09 Speaker 04 Okay.
44:09 Speaker 05 That's more directly triggering ovulation. But metformin can, and it has good data that it can like normalize ovulation to a regular degree, which can help with infertility if that's a goal. And then there's also interest, of course, in using newer medicines like GLP-1s, which are the Ozempics of the world, or other combination medicines. But we'll get there later in this episode, Erin.
44:37 Speaker 04 Quick questions.
44:40 Speaker 05 Give it to me.
44:41 Speaker 04 Menopause.
44:42 Speaker 05 Ah.
44:46 Speaker 05 Yes?
44:47 Speaker 04 Yeah.
44:48 Speaker 05 What's the question?
44:49 Speaker 04 Well, the question is like, I guess the question is a very vague, unformed question, but just like for people who have PCOS, is their menopause experience any different?
45:01 Speaker 05 This is such a great question. No idea.
45:04 Speaker 04 Okay, no, no one has examined it?
45:07 Speaker 05 All of these papers are like, hey, yeah, so a lot of what we know about PCOS, we think of as a reproductive disorder. And so its primary effects are in the reproductive years. So we don't have a lot of data on postmenopausal PCOS. Is the insulin resistance still a thing? Are you at higher risk for cardiovascular disease and type 2 diabetes postmenopausal compared to someone who has, like, does your PCOS still exist postmenopause?
45:33 Speaker 04 Right, that's what I was trying to, that's what I was trying to ask.
45:36 Speaker 05 That's a great question.
45:37 Speaker 04 The, I guess the, the other question then is, okay, so, and this maybe kind of gets into what I'm gonna talk about a little bit, but like, you get a diagnosis of PCOS. You are not interested in becoming pregnant. You maybe are not interested in addressing any of the other symptoms of PCOS. Is there anything in your medical care that is like, we should have increased screening for cardiovascular disease? We should have this and that. Is that something that physicians?
46:13 Speaker 05 Do?
46:13 Speaker 04 Do?
46:14 Speaker 05 Does anyone do it? Is the question I can't answer. That is the guidelines, though. That, those are the guidelines, especially from the 2023 update. You should be screened for, potentially for sleep apnea, which not everyone is necessarily needs to be screened for sleep apnea. But if you have PCOS, you probably should at least be screened with like some of the questionnaires. You should be screened for diabetes, so checking an A1C. You should be screened for hyperlipidemia. Even if you don't want to address any of the symptoms of hyperangiotinism, and it does not matter to you whether, like, you don't want to get pregnant, and so it doesn't matter to you if you're not ovulating on a regular schedule, you do need to think about endometrial protection. You have to do something to reduce that risk of endometrial cancer. So that is something that you have to think about.
46:58 Speaker 05 And yeah, that those, I mean, those are the main things. There's, there's probably more that, that I'm forgetting off the top of my head. Also, depression and anxiety are higher in people with PCOS. Why?
47:10 Speaker 04 Right.
47:10 Speaker 05 We don't know. Is that just because of how people are treated with PCOS by the medical system? How long it can take to get a diagnosis? How much they're like ignored by the medical system? We don't know. Is it just because, is it, does it actually have anything to do with PCOS? And the like pathology there? Or is it all just our medical system? We don't know.
47:29 Speaker 04 Yeah.
47:29 Speaker 05 But it's an important thing to keep in mind.
47:31 Speaker 04 And society.
47:32 Speaker 05 Yes, society, exactly.
47:37 Speaker 05 Aaron, that was only twice as long as I anticipated. So tell me, how did we get to here? What do we know?
47:47 Speaker 05 You know?
47:48 Speaker 04 Those are some great questions. Let's, um, let's get into it.
47:52 Speaker 05 Okay.
47:55 Speaker 01 Hey, I'm Nile Rodgers, producer, songwriter, guitarist and co-founder of the group Chic. A great song has a way of defining a moment, a moment of joy, heartbreak, or anything in between.
48:11 Speaker 01 This fall, I'll be driving across the country, dropping in on some of the coolest, most fascinating artists working today. We'll go deep into their lives and careers and hear what it was like before the moment that made them. From hit makers like Miguel.
48:28 Speaker 00 That last year, finishing that record was the hardest experience of my life. Regardless of how everyone else buys into this. I believe in this and I'm gonna push.
48:40 Speaker 01 To rising stars like Alex Warren.
48:43 Speaker 06 You know, a song is a story and the verse is setting the scene. And for me at least, it's allowing me to be personal and vulnerable with the audience. Whether it's about my wife and I'm being vulnerable about her, or it's about, you know, my parents and I'm being vulnerable to them. And it's almost like a cinematic piece in a way where each song tells that beautiful story.
49:01 Speaker 01 It's gonna be one hell of a trip. Experience Before the Moment, a Lincoln Original Series on the iHeartRadio app, YouTube, or wherever you get your podcasts.
49:13 Speaker 08 Hey, it's Lunchbox from the Bobby Bones Show. Buy smart, drive for less, and trade for more. That's Toyota affordability, and it starts with a great deal on an all-wheel-drive Camry, Corolla Cross, or a Corolla sedan with the latest features in tech. Or test drive a spacious Grand Highlander or an adventure-ready RAV4. And with so many hybrid models available, you can enjoy longer trips without all the stops, while Toyota's legendary resale value means you could get more at trade-in. Get a deal today and great value tomorrow. Shop toyota.com for deals and details. Toyota, let's go places.
50:04 Speaker 04 For all that we still don't know about the biology of PCOS, this condition can teach us so much when it comes to the power of societal expectations, the inadequacy of a name, our failure to provide care to all who need it, and how silence, stigma, and shame can profoundly deepen the impact of a medical condition. At least, it can teach us those things if we are willing to listen. Yeah, can we learn those things? Can we learn those things? Prevalence estimates of PCOS vary.
50:45 Speaker 04 The most common numbers I've seen are 6% to 20% of people assigned female at birth. Others say, you know, 1 in 10. A huge, huge prevalence. Right. And yet, PCOS receives less funding for research compared to other similarly prevalent conditions. There is less awareness, both in the medical community as well as within the general public, and we still lag behind in terms of treatment options and medical knowledge about PCOS. Clearly, not enough of us are listening. Hopefully, that will change, thanks to the incredible advocacy work by some groups and individuals, and thanks to the internet, which I never thought I'd say, but truly,
51:29 Speaker 04 thanks to the internet, where people with PCOS can find the support and community that is so often lacking in their everyday lives, or in interactions with their healthcare provider. Yeah. Before I go any further, I want to shout out one advocate in particular, and that is Dr. Stacy L. Williams, a social health psychologist at East Tennessee State University, and author of an incredible book that I read for this episode, titled The Psychology of PCOS: Building the Science and Breaking the Silence. As someone who does not have PCOS, but thought they knew a thing or two about it, which turned out to be true in the literal sense. Right.
52:11 Speaker 04 I found this book to be incredibly eye-opening and perspective-shifting, truly. And almost everything that I'm going to talk about when it comes to PCOS today, and some of the issues that we see, comes from this wonderful book. But before we get into today, and the today's landscape, let's go back in time to get a sense of the lengthy history of this condition. So PCOS is likely an ancient disease in humans, and it's probably not limited to our species. One of the challenges with understanding the root causes of PCOS is not having a naturally-occurring animal model. But I did come across a paper that described rhesus monkeys that had naturally-occurring
52:52 Speaker 04 high levels of testosterone, and seemed to exhibit some of the clinical picture of PCOS. Okay. It's still like, it's not clear. Yeah. You know? Yeah. The first likely descriptions of the condition in humans come from ancient Greece in Hippocrates' Diseases of Women text, written in the 4th century BCE. Oh, gosh, can't wait for this quote. "But those women whose menstruation is less than three days, or is meager, are robust, with a healthy complexion and a masculine appearance, yet they are not concerned about bearing children, nor do they become pregnant." End quote.
53:30 Speaker 05 Okay.
53:30 Speaker 04 Yep. Other ancient texts mention hercitus or hercitus in combination with changes in menses as a condition.
53:38 Speaker 05 Okay.
53:38 Speaker 04 And another Greek physician, Sorenus of Ephesus, wrote around the second century C E, quote, "Sometimes it is also natural not to menstruate at all. It is natural to in persons whose bodies are of a masculine type. We observe that the majority of those not menstruating are rather robust, like mannish and sterile women," end quote. I know. Language is not great.
54:04 Speaker 05 Not great, yeah.
54:06 Speaker 04 But what these descriptions show is that PCOS was likely an ancient disorder and common enough that it was mentioned in several old medical texts and that it has always been described as violating expectations of femininity.
54:21 Speaker 05 Mm hmm.
54:22 Speaker 04 The next description that historians point out comes from 1721, when an Italian physician, Valisneri, described a married, quote unquote, "infertile woman" who died young at 21 years and upon autopsy was found to have shiny ovaries with a white surface and the size of ovaries as pigeon eggs, or ovaries the size of pigeon eggs.
54:44 Speaker 05 Okay. I have no idea, like, how big a pigeon egg is.
54:48 Speaker 04 I'm not sure either. I should have looked it up.
54:50 Speaker 05 I imagine they're small, though. Like pigeons aren't very big birds.
54:53 Speaker 04 Yeah.
54:54 Speaker 05 Okay.
54:55 Speaker 04 I don't know.
54:55 Speaker 05 All right.
54:57 Speaker 04 Additional mentions of what was likely PCOS popped up throughout the 18th and 19th centuries, including from Rokitanski, the famous pathologist I mentioned before on the podcast, who did, like, tens of thousands of autopsies. And this period, especially in, like, the late 19th century, early 20th century, was crucial time for building a foundation of knowledge for understanding the role of different hormones in our physiology and what could happen when things do not go as expected. This was also when the testosterone equals male, estrogen equals female, false dichotomy was established.
55:34 Speaker 05 Oh, love that.
55:35 Speaker 04 Mm hmm. Yeah, still unlearning that, I think.
55:38 Speaker 05 Yeah.
55:39 Speaker 04 And so while that piece of the puzzle, like the hormone piece of the puzzle, wouldn't get slotted into PCOS until the 1960s, when researchers demonstrated the ovaries' role in producing androgens, a complete clinical picture of the condition was formed by 1935.
55:55 Speaker 05 Wow.
55:55 Speaker 04 More or less complete, yeah. That year, two physicians, Irving Freyler Stein and Michael Leo Leventhal, published a paper titled "Amenorrhea Associated With Bilateral Polycystic Ovaries."
56:07 Speaker 05 Okay.
56:07 Speaker 04 There you go. And in it, they described the case reports that they had collected over the previous few years while investigating factors underlying difficulty getting pregnant.
56:17 Speaker 05 Okay.
56:18 Speaker 04 They followed these patients for long periods of time and like truly got to know them, got to know their histories, got to know like just everything about them. It was sort of this like, you know what? Let's just cast a wide net and see what, what comes out. And by doing this, which is not a very common thing done today, they were able to draw out patterns that otherwise might have been missed. A subset of their patients had started menstruating years before, but their periods since had been unpredictable or just lacking entirely. They tended to have more hair growth than average and enlarged cystic ovaries, often larger than the uterus even. One, at least a few. And they performed surgeries on a few of their patients to remove the cysts and part of the ovaries,
57:03 Speaker 04 both for diagnostic as well as therapeutic purposes. And a couple of people actually delivered children after the surgery.
57:10 Speaker 05 Okay.
57:11 Speaker 04 So what was different about Stein and Leventhal's clinical picture? Like, why is this the one that put PCOS on the medical map, so to speak? They were the first to describe the triad of polycystic ovarian morphology, hercetism, and infrequent irregular periods.
57:29 Speaker 05 Okay.
57:29 Speaker 04 And of course, this is not a perfect clinical picture, which over the decades has evolved to account for more diverse symptoms and still maybe is, one could describe it as incomplete.
57:43 Speaker 05 Lacking, yes.
57:44 Speaker 04 Mm-hmm. And their focus on ovarian cysts, ultimately leading to the name Polycystic Ovary Syndrome, was misleading since cysts are not always present.
57:53 Speaker 05 Yeah.
57:53 Speaker 04 Or like, yeah, it's not, it's not quite accurate, you could say.
57:58 Speaker 05 I mean, if you, a cyst, just a fluid-filled thing, then sure, sure. We'll, we'll call it.
58:02 Speaker 04 Sure.
58:03 Speaker 05 Yeah, it doesn't have to be present.
58:05 Speaker 04 Yeah, doesn't have to be present, exactly.
58:08 Speaker 04 But what they did was provide a starting point and drive interest in this condition. And in the decades since, researchers have added detail and depth to what we know about PCOS, from diagnosis to possible treatments, but not nearly enough. To quote Dr. Stacy Williams, who's the author of The Psychology of PCOS, quote, "It is unfathomable that in the 21st century, we are still grappling with diagnosis and treatment for PCOS. After more than 85 years since PCOS was formally identified, doctors still lack knowledge of the syndrome. Combine that reality with the continued lack of cultural sensitivity of providers
58:51 Speaker 04 towards their patients, and we have a recipe for continued delays in diagnosis, biased interactions, and increased risk of worse health outcomes." End quote. Yeah. The resulting cost of this is huge. On the economic side, $8 billion annually in the US alone, that was estimated in 2022. For PCOS? For PCOS. Okay. And that's split about equally between reproductive issues and metabolic vascular issues. Okay. And is likely an underestimate. Mm-hmm. Erin, you took us through some of the physical costs associated with PCOS, some of which can be substantial.
59:34 Speaker 04 But the psychological costs of this condition can be immeasurable and mostly go unacknowledged, at least in the medical literature. PCOS, like many chronic conditions, reveals a divide between how society expects you to act, look, and feel, and how you actually act, look, and feel.
59:59 Speaker 04 The price for not meeting those expectations can be steep, whether it results from medical gaslighting, bullying, or internalized stigma. People with PCOS are at a higher risk of depression and anxiety, like you said, and it's difficult to disentangle whether these mental health impacts are a direct or indirect consequence of PCOS. Is it hormone dysregulation? Is it the medications someone has prescribed? Is it the stigma you face with PCOS? Is it not just one thing, but many? We don't have a good answer. But if we want to find one, what we need is more information, not just about the biological underpinnings of PCOS, but especially the lived experiences.
1:00:41 Speaker 04 What is it like to live with a condition whose symptoms mark you, visibly or invisibly, as not conforming to societal norms or medical expectations? How does our society or our medical establishment treat someone with PCOS? And how is that wrapped up in ingrained notions of gender and sexuality? Let's get into it.
1:01:05 Speaker 05 Okay.
1:01:06 Speaker 04 And I'm roughly breaking it down between outside of clinic and inside clinic.
1:01:12 Speaker 05 Okay.
1:01:13 Speaker 04 As you described, Erin, PCOS is associated with a broad array of signs and symptoms, some of which are visible, like, you know, what is called male pattern body hair or baldness, weight gain. Others which aren't visible, such as irregular periods, difficulty getting pregnant, but many of which challenge gender norms. Our society has hammered into us that women should not be hairy, that in fact, any body hair or facial hair is shameful and disgusting, and we should take steps to conceal it.
1:01:45 Speaker 05 And avoid it, laser it away.
1:01:47 Speaker 04 I mean, bearded ladies were a staple of circuses, for goodness sake. Our society equates fatness with a moral failing, believing that it demonstrates a lack of self-control, and women especially should be delicate, slender angels. Our society tells us we become women when we get our first period, and that our monthly bleeding is a powerful reminder of our womanhood.
1:02:11 Speaker 05 Oh, God. Sorry, makes me nauseous.
1:02:14 Speaker 04 Mm hmm. Our society assumes that every woman will want to give birth.
1:02:19 Speaker 05 Mm hmm.
1:02:20 Speaker 04 Our society expects that every person assigned female at birth should look a certain way, act a certain way, and want certain things.
1:02:27 Speaker 05 Mm hmm.
1:02:28 Speaker 04 And PCOS can throw a wrench into society's expectations.
1:02:33 Speaker 05 Yeah.
1:02:33 Speaker 04 Sometimes, because we are raised in this society and these expectations are deeply ingrained in us, this can lead to intense feelings of stigma that come from within. If you don't menstruate regularly, and menstruation, though itself is stigmatized, is associated with womanhood, does that mean that you are less of a woman? Of course not. But that is a difficult thing to unlearn.
1:02:59 Speaker 05 Right.
1:03:00 Speaker 04 The author of The Psychology of PCOS interviewed 50 people with the condition for the book and included snippets of the interviews, which were so insightful. Like, I loved that approach so much. I think it's so important, and I want to share a few throughout the rest of this. So Jo, late twenties, gender queer, non-binary, described being bullied for having male-patterned facial hair when they were younger, and said that they, quote, "spent a lot of time trying to get rid of my body hair, to the extent that nobody would even be able to know I even had it." So I feel that it's a cultural mandate for people who are trying to pass as women, that you can't have even stubble in places that you're not supposed to have hair, which is pretty much everywhere except your head.
1:03:45 Speaker 04 It's a lot of time and a lot of paranoia to try and maintain that appearance if that's not what your body is actually doing. And that was a big source of feeling invalidated as a woman for a long time, end quote. And like, okay, I don't have PCOS as far as I know, but I do have a lot of body hair, thanks genetics. And it has been, and continues to be, a source of shame and like embarrassment and anxiety in my life. And it was just like, it still, to this day, ugh, anyway.
1:04:18 Speaker 05 Yeah, no, it's very real.
1:04:19 Speaker 04 It's very real.
1:04:22 Speaker 04 And then there's another firsthand account or another like snippet I want to share from Kim, mid 30s cisgender, who said, quote, "Before I was diagnosed with PCOS, I really just felt like my body was broken. And I think I had a lot of shame around not understanding why I was having trouble with periods and what this pain was that other people in my life who menstruate don't have. So what was going on for me? Why was I weird? And I think that shame made me feel isolated because I couldn't talk about it or I didn't know I could talk about it." End quote.
1:04:55 Speaker 05 Mm hmm.
1:04:56 Speaker 04 Stigma can also arise from other people. One person interviewed in the book describes getting facial hair shavers for Christmas from their mom.
1:05:04 Speaker 05 Oh.
1:05:05 Speaker 04 Yeah. I mean, I was bullied all throughout middle school and high school for body hair.
1:05:12 Speaker 05 Oh.
1:05:13 Speaker 04 Yeah.
1:05:14 Speaker 05 Why? Oh, my gosh. Why body hair? Like?
1:05:17 Speaker 04 I mean, we could do a whole episode on that.
1:05:21 Speaker 05 I know. Maybe we should.
1:05:22 Speaker 04 Maybe we should. I think part of it too is like razor companies were like, oh, we're missing half the population.
1:05:27 Speaker 05 Yeah, yeah, yeah.
1:05:28 Speaker 04 You're disgusting.
1:05:29 Speaker 05 You're disgusting. Your hair is disgusting.
1:05:31 Speaker 04 It's unhealthy. It's unhygienic.
1:05:33 Speaker 05 Oh, yeah, yeah.
1:05:34 Speaker 04 Oh, it makes me so upset. And then Meg, early 20s cisgender, talks about a college field trip for her geography major involving canoeing. Quote, "The professor was concerned about my ability to canoe because I'm overweight. Therefore, I might not have enough stamina, even though I've been kayaking all my life and I'm very good at canoeing and kayaking." End quote.
1:05:56 Speaker 05 Yeah. I mean, that's.
1:05:58 Speaker 04 Mm hmm. Another person interviewed described how her parents don't really, quote unquote, "believe" in PCOS.
1:06:07 Speaker 05 What?
1:06:08 Speaker 04 And think that the weight is completely a matter of self-control.
1:06:13 Speaker 05 The amount of fat shaming.
1:06:15 Speaker 04 It's ridiculous.
1:06:18 Speaker 05 It's yeah.
1:06:18 Speaker 04 It's overwhelming. Yeah.
1:06:21 Speaker 05 Yeah.
1:06:22 Speaker 04 Yeah. Yeah. There is, there is nothing inherently shameful about any part of PCOS. But because we are exposed to societal expectations from the minute we are born, and multiple symptoms of PCOS do not align with those expectations, stigma remains a huge issue, whether that comes from within or from without.
1:06:47 Speaker 05 Yeah.
1:06:47 Speaker 04 But not everyone experiences PCOS in the same way. So for instance, some cisgender women may feel self-conscious about their facial hair. Others may be done performing femininity by removing that hair. And they're like, no, I'm growing it out.
1:07:01 Speaker 05 Right.
1:07:01 Speaker 04 I don't care.
1:07:01 Speaker 05 Doesn't bother me.
1:07:02 Speaker 04 And other people that don't identify as women may welcome that facial hair, feeling that it more closely aligns with their gender identity. Along those lines, infrequent or unpredictable periods might be a painful reminder to cisgender women who are trying to become pregnant, or a source of anxiety for those who do not want to be pregnant.
1:07:23 Speaker 05 Right.
1:07:23 Speaker 04 While absent periods might be the desired outcome for people who find them distressing since they do not align with their gender. And then there's, there's everything in between. People can feel a million different ways about these different symptoms.
1:07:36 Speaker 05 Yeah.
1:07:37 Speaker 04 Kendall, late twenties, non-binary, describes the mixed feelings that can arise. Quote, "But the gender dysphoria, like, I feel like PCOS actually helps a little bit. But it also kind of makes it worse because I'm having all these problems that revolve around my female anatomy. So it's kind of like a push and pull of two differing emotions. And before I felt as though I was ready to identify as transgender, it definitely made me feel terrible about my body, very much like I was unlikable, unattractive to other people. But now I feel the opposite. I feel like it makes me more attractive because I'm transgender now and I present masculinely. But at the same time, the health aspects, and if I don't watch myself, I could gain weight, then I will feel even worse about myself." End quote.
1:08:23 Speaker 05 Yeah.
1:08:25 Speaker 04 There hasn't been very much research on gender identity in PCOS, but one study looking at the experience of transgender men with PCOS found less gender dysphoria and less negative body image in those with PCOS compared to those without.
1:08:40 Speaker 05 Interesting.
1:08:40 Speaker 04 There is no hard and fast rule for how someone will experience PCOS. Maybe there's shame or stigma. Maybe there's confidence and power. Maybe there's discomfort or sadness. Maybe there's empathy and understanding. And maybe there's everything all at once or at different stages of your life. Each experience is unique and influenced by a person's inner and outer world. Do they have someone or a community of someones that supports, understands, and listens to them? Part of what perpetuates stigma in PCOS is a lack of awareness surrounding this condition. People don't know what it is. And since it affects those assigned female at birth, there's a tendency to assume that it's a gynecological disorder.
1:09:23 Speaker 04 And while we don't talk about anything down there.
1:09:26 Speaker 05 Down there. It's off limits.
1:09:28 Speaker 04 That's not for polite company. Yeah. And this unwillingness to engage with PCOS because it's seen as a quote unquote "women's disease" shrouds it in silence, leading to less understanding and less interest in both the general public as well as the medical community. Just as society has its expectations of what a woman should be, medicine has their own notion of what PCOS looks like and how it should be managed.
1:09:57 Speaker 05 Yeah, they do.
1:09:58 Speaker 04 Mm hmm. And often, this leads to a much narrower view of this condition that excludes people who might not fit the, you know, quote unquote, "typical" clinical picture.
1:10:08 Speaker 05 Right, which is phenotype A and B or classic PCOS.
1:10:11 Speaker 04 Yep, yep. And this results in delays in diagnosis and inappropriate treatment. Because of its impact on fertility, PCOS is often seen primarily as a condition of heterosexual women who are struggling to become pregnant. And treatment is prescribed accordingly.
1:10:29 Speaker 05 Yep.
1:10:30 Speaker 04 This erases the experience of so many people who do not fit that description. Oh, you've got irregular periods. Let's get you on some birth control so you'll bleed monthly, which doesn't take into consideration that someone might not want to have periods at all.
1:10:46 Speaker 05 Yeah.
1:10:47 Speaker 04 Maybe.
1:10:48 Speaker 05 I'm sorry, just like, this is my personal opinion, like, why would we want to have periods?
1:10:52 Speaker 04 Why?
1:10:53 Speaker 05 Every month?
1:10:53 Speaker 04 Why?
1:10:53 Speaker 05 But no, some people do. Some people, it's important, and some people definitely don't.
1:10:57 Speaker 04 Uh huh, absolutely. People feel different ways about this.
1:11:00 Speaker 05 Oh, shocking.
1:11:01 Speaker 04 There's no one way, yeah.
1:11:04 Speaker 04 Or maybe your doctor says, it's, you know, that facial hair, it's from your hormone imbalance. You're a good candidate for electrolysis. Let's set up an appointment for you. Again, pointing out ways that you don't conform to gender expectations and pressuring you into performing femininity and making you feel othered and rejected, whether or not it's well-intentioned. And then there's, you really need to try harder to lose weight. It's not healthy. Are you exercising at all? You should eat less processed foods.
1:11:33 Speaker 05 You're doing it to yourself.
1:11:34 Speaker 04 You're doing it to yourself, assuming that someone's weight is solely due to poor diet or poor health behaviors, not related to PCOS, and that someone's weight is entirely responsible for all their symptoms. Oh, you have pain? You should try to lose some weight.
1:11:49 Speaker 05 Also, assuming that their weight is the problem at all.
1:11:52 Speaker 04 Yes.
1:11:53 Speaker 05 Like, assuming that their weight, that their BMI is a problem, because obesity is a quote-unquote "disease." Like, oh, it drives me up the wall.
1:12:03 Speaker 04 And this, this weight bias in medicine can lead to disordered eating. Or maybe the doctor will say something like, okay, you're sure you don't want to become pregnant? Well, then there's not really anything you need to worry about.
1:12:17 Speaker 05 Oh, gosh. That one gives me palpitations.
1:12:20 Speaker 04 100%.
1:12:22 Speaker 04 And this is, you know, as you described, PCOS is associated with other health outcomes not related to fertility.
1:12:30 Speaker 05 Right.
1:12:31 Speaker 04 Diabetes, cardiovascular disease, high cholesterol, high blood pressure, fatty liver disease, endometrial cancer, metabolic syndrome. I mean, there's like.
1:12:37 Speaker 05 Yeah. Sleep apnea.
1:12:39 Speaker 04 Sleep apnea.
1:12:39 Speaker 05 Yeah.
1:12:41 Speaker 04 The, um, the author of the psychology of PCOS, who has the condition herself, said that in the 30 years since her diagnosis, no doctor has ever told her about these other health consequences. And I get, you know, N of one anecdote, but still, that is not a unique experience.
1:12:58 Speaker 05 Well, I, and I just have to say, this is where like, I honestly was so, I'm a primary care provider.
1:13:03 Speaker 04 Yeah.
1:13:04 Speaker 05 I care for people with PCOS all the time. I was so embarrassed by how little I knew about the extent of the metabolic complications.
1:13:13 Speaker 04 Yes.
1:13:14 Speaker 05 And how important they are, first of all, regardless of BMI, second of all, like, to at least screen for despite how flawed our screening tools might be.
1:13:23 Speaker 04 Mm hmm.
1:13:24 Speaker 05 And in, in everyone, like, I, it just, it, it is not as well known as it should be despite efforts to standardize these guidelines and get this information out there. And despite the fact that it is much better today than it was, like, prior to 2018.
1:13:37 Speaker 04 Yeah. I mean, that's, it's very true. Um, and I, I have a, a study that, uh, was reported on, it was back in 2007, so prior to 2018, but it was testing US medical residents' knowledge of PCOS.
1:13:51 Speaker 05 Ooh, I bet it was bad.
1:13:52 Speaker 04 Oh, they found that they scored on average 50%.
1:13:55 Speaker 05 Ooh.
1:13:56 Speaker 04 And that only a subset scored higher than 70%, like, who were specializing in women's health, I think.
1:14:01 Speaker 05 Okay, yeah.
1:14:02 Speaker 04 Uh huh, uh huh. That is abysmal.
1:14:05 Speaker 05 Mm hmm.
1:14:06 Speaker 04 For a condition that affects one in 10 people, conservatively, assigned female at that birth.
1:14:12 Speaker 05 Yes.
1:14:12 Speaker 04 It's inexcusable. And that's also an underestimate, right? Like. One estimate I saw suggested that 70% of cases go undiagnosed.
1:14:21 Speaker 05 Wow.
1:14:23 Speaker 04 Yeah, yeah. If you don't fit the classical clinical picture, phenotype A and B, your doctor might dismiss you. They'll point out your weight and say, "But you're not obese. I don't think it's PCOS. You're thin." Or, "Well, you're older. Maybe your periods are just slowing down," even if they've been, quote unquote, "slow" your whole life.
1:14:44 Speaker 04 Delays in diagnosis for PCOS are exacerbated by race, by socioeconomic status, and by gender identity. The term "women's health," along with all the other gendered language surrounding PCOS, illustrates this. But of course, this doesn't apply to all healthcare providers, and some people have really great experiences with their individual providers. But even for them, even for those providers, an overall lack of knowledge about PCOS is limiting. What might the trans non-binary experience be like for someone with PCOS? What do we know about hormone replacement therapy and PCOS? Is a healthcare provider equipped to answer those questions or willing to look for the answers? Do the answers even exist?
1:15:29 Speaker 04 There needs to be a shift in the way that we diagnose, treat, study, and talk about PCOS. We need to incorporate mental health care, do a better job educating healthcare providers, raise awareness with the general public, improve treatment options, conduct more research into every aspect of this, and have more compassion and self-compassion. Unfortunately, these changes won't happen overnight, but progress is being made by advocacy groups, by online communities where people can learn and share, and by some researchers who are trying to better understand this condition. And so, speaking of which, I'll turn it over to you, Erin, to tell us where we stand today when it comes to PCOS.
1:16:13 Speaker 05 I can't wait. I have a huge surprise for you, Erin.
1:16:17 Speaker 04 Oh, okay.
1:16:18 Speaker 05 I'm gonna take this whole thing in these last 10 minutes and turn it on its head, and then drop the mic and walk away. Ready?
1:16:26 Speaker 04 Okay, yes, please.
1:16:54 Speaker 05 You said already, most papers cite an estimated prevalence anywhere between five or six and 20%. Most of the newer papers, like the newest 2023 guidelines, said maybe 10 to 13%.
1:17:07 Speaker 04 Okay.
1:17:08 Speaker 05 But we don't know. The prevalence is thought to me relatively homogeneous across the globe with maybe slightly higher prevalence in people of Southeast Asian descent and Eastern Mediterranean descent. What's underlying that? We don't know.
1:17:22 Speaker 04 Right.
1:17:23 Speaker 05 And there's maybe some data that it's increasing in the recent decades, but it's very unclear to me whether this is related to any true increases in incidence or just increasing awareness and diagnosis.
1:17:36 Speaker 04 Yeah.
1:17:37 Speaker 05 Or things like that. So when it comes to current research, you laid it out for us really nicely, Erin. There's a lot to be desired. For me, I kind of just was like, what do I want to know about PCLS? We know how much insulin resistance is a major factor, but we don't have any assays that can really measure insulin resistance. So I'd love, I'd love more research on that. And there's certainly people doing that. And there are ways to measure it. It's just that they're not easy to do clinically. They're like very time intensive, labor intensive, expensive, so they can't be used. So then people are trying to come up with like, okay, what is something that we can use that, that like measures up to these gold standard versions?
1:18:20 Speaker 05 There's also a lot of work that needs to be done, that is being done on like, understanding some of this kind of higher level, what is this underlying cause? What is linking insulin resistance and this hyperandrogenism? Are these kiss peptides and other like peptides and receptors in our brain, in our hypothalamus? Are those involved? Do we have a master regulator switch that we can find that we could target? We don't know, but a lot of people are working on potentially looking at other targets for medications. I mentioned GLPs. These are all the rage right now. GLP-1 receptor agonists, we need to do an episode on these.
1:19:04 Speaker 04 I know.
1:19:05 Speaker 05 I know. They, what they would be targeting is in part this insulin resistance because what they help do is kind of regulate insulin release from our pancreas. And so there was a study that came out recently that looked at GLP-1s alone plus really interesting combinations of GLP's plus other medicines, including estrogen for PCOS. And they found that in some, at least in this study, which was on mice and rats, I actually don't remember if it was mice or rats, but they found a better treatment, like alleviation of all of the various things that they look at in mice and rats with PCOS than compared to metformin, which is very interesting, the GLP plus estrogen combination.
1:19:50 Speaker 04 Yeah. GLP, the effects are so broad.
1:19:54 Speaker 05 So broad.
1:19:55 Speaker 04 It's really fascinating. And it goes like way beyond, it's like, you know, weight loss from GLP-1s versus
1:20:05 Speaker 04 weight loss from not GLP-1s. And it's like, there are extra effects.
1:20:09 Speaker 05 Oh, yeah.
1:20:10 Speaker 04 Like, it's just like, what's happening?
1:20:11 Speaker 05 Well, and like the cardio, the cardiologists are so stoked on them. The cardiovascular effects are so good. The kidney protection, the nephrologists love them.
1:20:19 Speaker 04 Episode on GLP-1s and cardiovascular disease and heart failure especially. So if you are interested, check it out.
1:20:25 Speaker 05 It's, it's pretty major. They're also still very expensive and any new drugs that have come out will going to be even more expensive. So that's another thing to know. But here's where I want to take this whole table and flip it over.
1:20:39 Speaker 04 Ooh.
1:20:40 Speaker 05 Ready for this? We have talked so far exclusively about PCOS, polycystic ovarian morphology as a disease of people assigned female at birth, as in people with ovaries.
1:20:55 Speaker 04 Uh huh.
1:20:56 Speaker 05 However. Polycystic ovarian morphology is not necessary to the definition, right? And in fact, the presence of ovaries themselves may not be necessary in the metabolic phenotype of PCOS. That's a quote from one of the papers. Because we see very similar metabolic abnormalities and very similar hormonal disruptions in terms of free testosterone, DHEAS, sex hormone binding globulin, looking at all of these hormones in both people assigned female at birth with ovaries and in people with testicles.
1:21:36 Speaker 04 All right, so.
1:21:38 Speaker 05 Uh huh.
1:21:39 Speaker 04 What's happening, Erin?
1:21:40 Speaker 05 What's happening, Erin? I dug deep into this.
1:21:43 Speaker 04 I'm glad.
1:21:43 Speaker 05 Because there is a male equivalent that likely exists. However, it does not have a clinical definition. It does not have any clinical criteria. There are plenty of papers on it. Let's get into it.
1:21:57 Speaker 04 Yeah.
1:21:58 Speaker 05 We see in family members, like male family members of people with PCOS, either siblings of or children of people with PCOS, increased incidence in things like early onset androgenic alopecia, so male pattern hair loss before age 35. We also see increases in metabolic syndromes, including insulin resistance, type 2 diabetes, dyslipidemia, hypertension, cardiovascular disease. And in studies that have actually looked at this, we see a similar androgenic hormone profile. We can see increases in things like DHEAS. We can see increases in anti-mularian hormone, males also make it, and LH and FSH. And sometimes we see, sometimes we see a decrease in free testosterone, but
1:22:43 Speaker 05 then an increase in these other types of testosterones and things. So anyways, it is hypothesized, based on all of this, that first of all, there is in fact a similar metabolic and hormonal profile that is essentially a male equivalent, a person with testes equivalent to PCOS, and that early onset male.
1:23:07 Speaker 05 Pattern hair loss is possibly one like physical visual marker for this syndrome, except that about 30% of people assigned male at birth have early onset androgenic alopecia. So does that mean that it's just not as specific as a marker? Does it mean that the incidence is higher? What, what does that mean? We don't know.
1:23:27 Speaker 04 There are multiple causes of it that yeah, are not related to this syndrome. Yeah.
1:23:31 Speaker 05 And when we look at like the actual gene loci that we know are associated with PCOS, we see those gene loci in these males that have these other symptoms. And yet, when I, for example, went on Up to Date, which is where I often go as a clinician, but also when I'm like, does this, did I just miss this? It is nowhere mentioned on the PCOS page. When I tried to look up like male equivalent PCOS, it does not, it's not a thing, Erin, because we don't have any test for it.
1:23:58 Speaker 04 Or presumably very many treatments if somebody wants.
1:24:04 Speaker 05 It would be the same things in terms of like the metabolic symptoms, right? So we'd be talking about, we'd be talking about metformin, we would be talking about maybe these other things. What would we need to do to treat the male pattern hair loss? Maybe we do the, the same kinds of things that we would do in females. But yeah, we don't, we don't have, Erin, we don't, we do not. This is not recognized as a clinical condition. I want to make that very clear. But it is recognized in the literature dating back a couple of decades.
1:24:36 Speaker 04 Huh.
1:24:37 Speaker 05 At least a decade.
1:24:41 Speaker 05 And I feel like this highlights, so PCOS for me, like the biggest takeaways that I have from PCOS, aside from just like how much we don't know.
1:24:48 Speaker 04 Yeah.
1:24:49 Speaker 05 Is first of all, how much what we think of as binaries in medicine are spectrums, right?
1:24:58 Speaker 04 Yeah.
1:24:59 Speaker 05 And where we put our cutoff markers? What is abnormally high testosterone for a female? What is abnormally low free testosterone for a male? All of this is somewhat arbitrary, right? And we've known this for a long time, but it becomes so much more important when we're looking at a condition like PCOS, right?
1:25:20 Speaker 04 I find it very interesting, like this is, I think that yes, this is very revealing of, of the way that medicine considers.
1:25:30 Speaker 04 Bodies and binaries.
1:25:32 Speaker 05 Yes.
1:25:33 Speaker 04 And I'm just like thinking about this, like the male version of PCOS. What does that like, that should be able to tell us more about the root cause of it.
1:25:45 Speaker 05 It should, right. It should. If we started looking at it.
1:25:48 Speaker 04 If we started looking at it. Why, why aren't we looking at it?
1:25:51 Speaker 05 I mean, there are people who are, right? Because these papers exist.
1:25:54 Speaker 04 I know, but you said that this is, this is two decades old or people started looking at this.
1:25:58 Speaker 05 Two might have been, it's more than 10 years old. So two decades might have been an exaggeration. I don't remember when the first paper was.
1:26:04 Speaker 04 Okay, okay. Because I feel like in this case then, that the thing that really struck me about PCOS is that we are failing to capture people. We are failing to meet the needs that they have in many different ways. Sometimes that means we're not giving them the treatments that they want. We're not diagnosing them. Sometimes it means that we are giving them treatments they don't want.
1:26:29 Speaker 05 Right.
1:26:29 Speaker 04 And that, oh, the birth control actually is, worsens your symptoms of anxiety and depression. And also, I don't want periods, so I don't need to bleed monthly.
1:26:42 Speaker 04 But we also, it's just like, it shows our narrow view of this.
1:26:49 Speaker 05 Yeah.
1:26:49 Speaker 04 And how difficult it is to change these, to change these perspectives and to like, and actually broaden a clinical picture of something.
1:26:59 Speaker 05 It also, for me, highlights how stigmatized women's health is.
1:27:07 Speaker 04 A hundred percent.
1:27:08 Speaker 05 Because if you label a disease polycystic ovarian syndrome, inherently, you assume it only affects people with ovaries, which means that we're ignoring it, we're dismissing it, we're not funding its research, which means that everyone's health is compromised because women's health affects men's health too.
1:27:30 Speaker 04 Women's health is health. It's human health.
1:27:31 Speaker 05 It is human health, okay? And whether you have ovaries or whether you have testes, we should be looking at this.
1:27:37 Speaker 04 Mm hmm, mm hmm.
1:27:39 Speaker 05 So that's like my big rant.
1:27:41 Speaker 04 I feel like I have learned so, so much.
1:27:45 Speaker 05 Uh huh.
1:27:46 Speaker 04 About everything, about medicine, about PCOS, but also about medicine and society and perspectives.
1:27:53 Speaker 05 Yeah. I know. And it just, yeah, I, there's so much, there's so much still that we don't know. Especially like you were saying about the like, long-term potential for complications, postmenopausal PCOS, PCOS intestines. You can't call it PCOS. There's a paper that isn't yet published, actually. It's printed as a pre-print. So presumably it will be published soon, but I do have a link to it that's about how we need to rename PCOS because it's such a false name, like it's such a misnomer.
1:28:26 Speaker 05 And so we'll see what, what changes. Maybe, maybe it will change soon. What will we call it? I don't know.
1:28:32 Speaker 04 Someone was like this, I feel like I read something somewhere and I wish I'd kept the quote in, but it was like, the, this name is so ingrained in medicine that it was, it's going to be as, as easy to change the name and get people to accept it as it is to find the ultimate cause, which will then force a name re-changing or something like that, or name change.
1:28:54 Speaker 05 Yeah, I know.
1:28:55 Speaker 04 Yeah.
1:28:57 Speaker 05 Well, if you want to read so much more.
1:28:58 Speaker 04 So much.
1:28:59 Speaker 05 We can tell you so much about it, or where to find it, rather, on our website.
1:29:05 Speaker 04 Yep. Okay. I, once again, the book, The Psychology of PCOS by Dr. Stacey Williams, great book, check it out. And then for like, the overall history kind of part of it, there was a paper, I have a few, but there was a paper by Aziz and Adashi from 2016 called Stein and Leventhal, 80 Years On.
1:29:23 Speaker 05 I've got links to both the 2023 and the 2018 guidelines on the recommendations, like evidence-based recommendations for assessment and management. So those are both there. Two papers that I loved that were just overviews of PCOS. One was from the Lancet Diabetes and Endocrinology from 2022, just titled Polycystic Ovarian Syndrome.
1:29:44 Speaker 05 And the other one is from BMJ Medicine from 2023 titled Polycystic Ovary Syndrome: Pathophysiology and Therapeutic Opportunities. And then those couple of papers that I loved about the male equivalent of PCOS, one was titled Male Equivalent Polycystic Ovary Syndrome: Hormonal, Metabolic, and Clinical Aspects, and that was by DiGuardo et al. from 2020. And there's another one too, from 2018. So you can find the list of sources from this episode and all of our episodes on our website, thispodcastwillkillyou.com, under the Episodes tab.
1:30:20 Speaker 04 Yep, you can. Thank you again to Logan for providing the firsthand account. We cannot, we don't have the words to thank you, but it means so much. Thank you, thank you.
1:30:31 Speaker 05 It does. Thank you so much.
1:30:34 Speaker 04 Thank you to Blood Mobile for providing the music for this episode and all of our episodes.
1:30:39 Speaker 05 Thank you to Leanna and Tom and Brent and Pete and Mike and Jess and everyone else at Exactly Right for making all of this possible.
1:30:48 Speaker 04 Yes, thank you. And thank you to you listeners. We hope that you also learned something from this, or I don't know. Yeah. Tell us what you think.
1:30:59 Speaker 05 If you knew all of this already, wow. Yeah, that's impressive. Teach us something, please. And thank you, as always, to our patrons. Your support means the absolute world to us. Thank you.
1:31:11 Speaker 04 Thank you. Well, until next time, wash your hands.
1:31:14 Speaker 05 You filthy animals.
1:32:12 Speaker 09 This is Colin Cowherd from the Colin Cowherd Podcast. Buy smart, drive for less, and trade for more. That's Toyota Fordability. All starts with a great deal on an off-road ready Tacoma or a half-ton Tundra to a Toyota's most capable and longest-lasting trucks. Built on a reputation for quality and reliability, Toyota trucks are known for holding their value, which could mean big savings when it's time for your next Toyota. For a great deal today to a great value tomorrow. Shop toyota.com. Toyota, let's go places.
1:32:44 Speaker 01 Hey, I'm Niall Rogers. This fall, I'll be driving across the country, meeting some of today's coolest and most fascinating artists. We'll explore the stories before the moments that changed everything. Because every musician remembers the moment where it all began. Experience Before the Moment, a Lincoln original series on the iHeart Radio app, YouTube, or wherever you get your podcasts.
Previous Ep 180 Food Dyes: It’s all marketing Next Special Episode: Wendy Chin-Tanner & King of the Armadillos Page updated November 1, 2026 · transcript and summary are machine-generated